美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
68001-172-00	68001-172	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20140122	N/A	ANDA	ANDA202323	BluePoint Laboratories	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-172-00)
68001-171-00	68001-171	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20140122	N/A	ANDA	ANDA202323	BluePoint Laboratories	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-171-00)
16729-078-17	16729-078	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20131031	N/A	ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-17)
16729-078-01	16729-078	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20130613	N/A	ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	25 mg/1; 100 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-078-01)
16729-079-01	16729-079	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20130613	N/A	ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-01)
16729-079-17	16729-079	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA	Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20131115	N/A	ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	50 mg/1; 200 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-17)